Troy Lowe

Use of Artificial Intelligence in Developing Cost-Effective Respiratory Medicines

Medicine & Technology The industry faces significant challenges as average drug development costs exceed $1 billion, and timelines span over a decade. However, AI and machine learning (ML) offer powerful tools to alter respiratory drug development and significantly reduce costs. Sunilkumar Patel, director of Analytical Research and Development at Amneal Pharmaceuticals, leads this advancement, changing the respiratory care industry with his work.
Most Popular

Recommended Stories

Real Time Analytics